Regeneron and Alnylam announce collaboration to discover new treatments for NASH
Regeneron announced a collaboration to identify RNAi therapeutics for the chronic liver disease nonalcoholic steatohepatitis and potentially other related diseases. The discovery collaboration is based on a new Regeneron publication in the New England Journal of Medicine. March 21, 2018